Ptc Therapeutics annual gross profit
2015
2016
2017
2018
2019
2022
2023
2024
2025
Ptc Therapeutics Gross Profit Growth & History (PTCT)
Ptc Therapeutics's gross profit was $1.68B for fiscal 2025.
View full Ptc Therapeutics company overviewPtc Therapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.68B | $934.3M | +124.67% |
| 2024 | 2024-12-31 | $749.4M | −$123.0M | −14.09% |
| 2023 | 2023-12-31 | $872.3M | $218.2M | +33.36% |
| 2022 | 2022-12-31 | $654.1M | — | — |
| 2019 | 2019-12-31 | $294.8M | $42.8M | +16.97% |
| 2018 | 2018-12-31 | $252.1M | $62.2M | +32.79% |
| 2017 | 2017-12-31 | $189.8M | $107.1M | +129.51% |
| 2016 | 2016-12-31 | $82.7M | $45.9M | +124.95% |
| 2015 | 2015-12-31 | $36.8M | — | — |
Ptc Therapeutics quarterly gross profit
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $340.6M | $173.1M | +103.40% |
| Q1 2026 | 2026-03-31 | $244.5M | — | — |
| Q4 2025 | 2025-12-31 | $157.7M | — | — |
| Q3 2025 | 2025-09-30 | $195.2M | — | — |
| Q2 2025 | 2025-06-30 | $167.5M | — | — |
| Q4 2019 | 2019-12-31 | $92.9M | $10.3M | +12.52% |
| Q3 2019 | 2019-09-30 | $68.4M | $18.1M | +36.01% |
| Q2 2019 | 2019-06-30 | $82.3M | $16.1M | +24.39% |
| Q1 2019 | 2019-03-31 | $51.2M | −$1.8M | −3.41% |
| Q4 2018 | 2018-12-31 | $82.6M | $6.5M | +8.54% |
| Q3 2018 | 2018-09-30 | $50.3M | $10.1M | +25.13% |
| Q2 2018 | 2018-06-30 | $66.2M | $19.0M | +40.39% |
| Q1 2018 | 2018-03-31 | $53.0M | $26.6M | +100.80% |
| Q4 2017 | 2017-12-31 | $76.1M | $50.9M | +202.02% |
| Q3 2017 | 2017-09-30 | $40.2M | $17.2M | +74.88% |
| Q2 2017 | 2017-06-30 | $47.1M | $31.5M | +201.50% |
| Q1 2017 | 2017-03-31 | $26.4M | $7.5M | +39.74% |
| Q4 2016 | 2016-12-31 | $25.2M | — | — |
| Q3 2016 | 2016-09-30 | $23.0M | — | — |
| Q2 2016 | 2016-06-30 | $15.6M | — | — |
| Q1 2016 | 2016-03-31 | $18.9M | — | — |
Ptc Therapeutics gross profit trends
Between the periods ended 2015-12-31 and 2025-12-31, Ptc Therapeutics's gross profit increased from $36.8M to $1.68B, a change of $1.65B. The latest reported quarter, Q2 2026, shows $340.6M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ptc Therapeutics source filings ↗